Modified Diet Trial: A Study of SMT C1100 in Paediatric Patients With DMD Who Follow a Balanced Diet
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
Placebo-controlled, multi-centre, randomized, double-blind dose escalation study. The aim is
to evaluate the pharmacokinetics (PK) and safety of SMT C1100 in paediatric patients with
Duchenne Muscular Dystrophy (DMD) who follow a balanced diet.